DeSimone Jill 4
4 · Kinnate Biopharma Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
DeSimone Jill
Director
Transactions
- Award
Stock Option (right to buy)
2023-03-01+50,000→ 50,000 totalExercise: $5.21Exp: 2033-03-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]1/36th of the shares underlying the Option vest and become exercisable on each monthly anniversary of the Date of Grant.